Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. (April 2022)
- Record Type:
- Journal Article
- Title:
- Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. (April 2022)
- Main Title:
- Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach
- Authors:
- Cearns, Micah
Amare, Azmeraw T.
Schubert, Klaus Oliver
Thalamuthu, Anbupalam
Frank, Joseph
Streit, Fabian
Adli, Mazda
Akula, Nirmala
Akiyama, Kazufumi
Ardau, Raffaella
Arias, Bárbara
Aubry, Jean-Michel
Backlund, Lena
Bhattacharjee, Abesh Kumar
Bellivier, Frank
Benabarre, Antonio
Bengesser, Susanne
Biernacka, Joanna M.
Birner, Armin
Brichant-Petitjean, Clara
Cervantes, Pablo
Chen, Hsi-Chung
Chillotti, Caterina
Cichon, Sven
Cruceanu, Cristiana
Czerski, Piotr M.
Dalkner, Nina
Dayer, Alexandre
Degenhardt, Franziska
Zompo, Maria Del
DePaulo, J. Raymond
Étain, Bruno
Falkai, Peter
Forstner, Andreas J.
Frisen, Louise
Frye, Mark A.
Fullerton, Janice M.
Gard, Sébastien
Garnham, Julie S.
Goes, Fernando S.
Grigoroiu-Serbanescu, Maria
Grof, Paul
Hashimoto, Ryota
Hauser, Joanna
Heilbronner, Urs
Herms, Stefan
Hoffmann, Per
Hofmann, Andrea
Hou, Liping
Hsu, Yi-Hsiang
Jamain, Stephane
Jiménez, Esther
Kahn, Jean-Pierre
Kassem, Layla
Kuo, Po-Hsiu
Kato, Tadafumi
Kelsoe, John
Kittel-Schneider, Sarah
Kliwicki, Sebastian
König, Barbara
Kusumi, Ichiro
Laje, Gonzalo
Landén, Mikael
Lavebratt, Catharina
Leboyer, Marion
Leckband, Susan G.
Maj, Mario
Manchia, Mirko
Martinsson, Lina
McCarthy, Michael J.
McElroy, Susan
Colom, Francesc
Mitjans, Marina
Mondimore, Francis M.
Monteleone, Palmiero
Nievergelt, Caroline M.
Nöthen, Markus M.
Novák, Tomas
O'Donovan, Claire
Ozaki, Norio
Millischer, Vincent
Papiol, Sergi
Pfennig, Andrea
Pisanu, Claudia
Potash, James B.
Reif, Andreas
Reininghaus, Eva
Rouleau, Guy A.
Rybakowski, Janusz K.
Schalling, Martin
Schofield, Peter R.
Schweizer, Barbara W.
Severino, Giovanni
Shekhtman, Tatyana
Shilling, Paul D.
Shimoda, Katzutaka
Simhandl, Christian
Slaney, Claire M.
Squassina, Alessio
Stamm, Thomas
Stopkova, Pavla
Tekola-Ayele, Fasil
Tortorella, Alfonso
Turecki, Gustavo
Veeh, Julia
Vieta, Eduard
Witt, Stephanie H.
Roberts, Gloria
Zandi, Peter P.
Alda, Martin
Bauer, Michael
McMahon, Francis J.
Mitchell, Philip B.
Schulze, Thomas G.
Rietschel, Marcella
Clark, Scott R.
Baune, Bernhard T.
… (more) - Editors:
- Upthegrove, Rachel
Dwyer, Dominic
Kambeitz-Ilankovic, Lana
Krishnadas, Rajeev - Other Names:
- collab.
- Abstract:
- Abstract : Background: Response to lithium in patients with bipolar disorder is associated with clinical and transdiagnostic genetic factors. The predictive combination of these variables might help clinicians better predict which patients will respond to lithium treatment. Aims: To use a combination of transdiagnostic genetic and clinical factors to predict lithium response in patients with bipolar disorder. Method: This study utilised genetic and clinical data ( n = 1034) collected as part of the International Consortium on Lithium Genetics (ConLi + Gen) project. Polygenic risk scores (PRS) were computed for schizophrenia and major depressive disorder, and then combined with clinical variables using a cross-validated machine-learning regression approach. Unimodal, multimodal and genetically stratified models were trained and validated using ridge, elastic net and random forest regression on 692 patients with bipolar disorder from ten study sites using leave-site-out cross-validation. All models were then tested on an independent test set of 342 patients. The best performing models were then tested in a classification framework. Results: The best performing linear model explained 5.1% ( P = 0.0001) of variance in lithium response and was composed of clinical variables, PRS variables and interaction terms between them. The best performing non-linear model used only clinical variables and explained 8.1% ( P = 0.0001) of variance in lithium response. A priori genomicAbstract : Background: Response to lithium in patients with bipolar disorder is associated with clinical and transdiagnostic genetic factors. The predictive combination of these variables might help clinicians better predict which patients will respond to lithium treatment. Aims: To use a combination of transdiagnostic genetic and clinical factors to predict lithium response in patients with bipolar disorder. Method: This study utilised genetic and clinical data ( n = 1034) collected as part of the International Consortium on Lithium Genetics (ConLi + Gen) project. Polygenic risk scores (PRS) were computed for schizophrenia and major depressive disorder, and then combined with clinical variables using a cross-validated machine-learning regression approach. Unimodal, multimodal and genetically stratified models were trained and validated using ridge, elastic net and random forest regression on 692 patients with bipolar disorder from ten study sites using leave-site-out cross-validation. All models were then tested on an independent test set of 342 patients. The best performing models were then tested in a classification framework. Results: The best performing linear model explained 5.1% ( P = 0.0001) of variance in lithium response and was composed of clinical variables, PRS variables and interaction terms between them. The best performing non-linear model used only clinical variables and explained 8.1% ( P = 0.0001) of variance in lithium response. A priori genomic stratification improved non-linear model performance to 13.7% ( P = 0.0001) and improved the binary classification of lithium response. This model stratified patients based on their meta-polygenic loadings for major depressive disorder and schizophrenia and was then trained using clinical data. Conclusions: Using PRS to first stratify patients genetically and then train machine-learning models with clinical predictors led to large improvements in lithium response prediction. When used with other PRS and biological markers in the future this approach may help inform which patients are most likely to respond to lithium treatment. … (more)
- Is Part Of:
- British journal of psychiatry. Volume 220:Number 4(2022)
- Journal:
- British journal of psychiatry
- Issue:
- Volume 220:Number 4(2022)
- Issue Display:
- Volume 220, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 220
- Issue:
- 4
- Issue Sort Value:
- 2022-0220-0004-0000
- Page Start:
- 219
- Page End:
- 228
- Publication Date:
- 2022-04
- Subjects:
- Mood stabilisers -- bipolar affective disorders -- genetics -- outcome studies -- depressive disorders
Psychiatry -- Periodicals
Psychology, Pathological -- Periodicals
616.89005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00002405-000000000-00000 ↗
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry ↗
http://bjp.rcpsych.org ↗ - DOI:
- 10.1192/bjp.2022.28 ↗
- Languages:
- English
- ISSNs:
- 0007-1250
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21227.xml